| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $3.99M | $3.96M | $2.68M | $1.29M | $127.13K |
| R&D | – | – | – | – | – |
| SG&A | $84.03K | $56.91K | $463.87K | $164.93K | $60.58K |
| Operating Income | – | – | – | – | – |
| Interest Expense | – | – | – | – | – |
| Tax Expense | – | – | – | – | – |
| Net Income | -$3.73M | -$3.56M | -$2.65M | -$1.56M | -$692.57K |
| EPS (basic) | 0.1300 | 0.1400 | -0.2100 | -0.5100 | -0.1600 |
| EPS (diluted) | 0.1300 | 0.1400 | -0.2100 | -0.5100 | – |
| Shares (diluted) | $28.01M | $26.15M | $12.59M | $3.03M | – |